ArticleRheumatology and therapy2018

Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.

Peter Nash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.